Post PCI Same Day Discharge: from Convenience to Need

Same day discharge following programed PCI with no complications has been a way for health centers to reduce costs that has resulted both safe and convenient for patients. 

Alta el mismo día post angioplastia: de una comodidad a una necesidad

With the arrival of the pandemic, reduced bed capacity, uninfected patient exposure and their potential contagion, and the always pressing need to reduce hospital costs have turned same day discharge into a necessity for many centers. 

Fortunately, the evidence on safety of same day discharge had already been shown before COVID-19, and the latter has made many operators feel they needed to implement it. 

This study included 819,091 patients undergoing programed PCI in 1,716 centers. It looked at the link between same day discharge and 30-day mortality in addition to rehospitalization.  

In this series, 14% were discharged the same day, though the proportion increased at followup: it went from a mere 4.5% at the beginning to almost 30% towards the end. This percentage grew according to an increased use of the transradial approach instead of the femoral. 

Mortality at 30 days resulted identical throughout the followup period, even though the adjusted risk of rehospitalization dropped, and this effect was more significative for patients discharged the same day (p for interaction <0.001).


Read also: AHA 2020 | Rise in Early Discharge After TAVR Has the Expected Cost.


This strategy of established safety (together with the transradial approach) can be an effective tool to keep doing programed PCI procedures during the pandemic. 

Conclusion

Same day discharge after elective PCI has been on the rise since the beginning of this practice. Mortality has not been compromised and re-hospitalization has actually dropped, which confirms the safety of this strategy. 

In pandemic times, same day discharge might have some perks. 

Original Title: Trends in Use and Outcomes of Same-Day Discharge Following Elective Percutaneous Coronary Intervention.

Reference: Steven M Bradley et al. JACC Cardiovasc Interv. 2021 Aug 9;14(15):1655-1666. doi: 10.1016/j.jcin.2021.05.043.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Left or Right Transradial Approach? Comparing Radiation Exposure in Coronary Procedures

Radiation exposure during percutaneous procedures is a problem both for patients and operators. The transradial is currently the preferred approach, vs. femoral; however, whether...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....